CareDx Balance Sheet Health
Financial Health criteria checks 6/6
CareDx has a total shareholder equity of $273.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $477.0M and $203.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$240.85m |
| Equity | US$273.25m |
| Total liabilities | US$203.74m |
| Total assets | US$476.99m |
Recent financial health updates
No updates
Recent updates
The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 26%
Nov 05
CareDx Resolves Key Issues: Poised For Growth In Transplant Diagnostics
Sep 29CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Aug 01CareDx: Benefiting From Some Certainty
Jul 15Why Investors Shouldn't Be Surprised By CareDx, Inc's (NASDAQ:CDNA) 28% Share Price Plunge
Apr 27CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 40% But Its Business Prospects Need A Lift Too
Mar 02CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 26% But Its Business Still Trails The Industry
Dec 27CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Dec 27Benign Growth For CareDx, Inc (NASDAQ:CDNA) Underpins Its Share Price
Jun 29Analyst Forecasts Just Became More Bearish On CareDx, Inc (NASDAQ:CDNA)
May 16CareDx: Shaking Off First-Mover Disadvantage
Oct 18CareDx: Best Near Cap-Gain Health Diagnostics Prospect Say Market Makers
Aug 08Financial Position Analysis
Short Term Liabilities: CDNA's short term assets ($334.1M) exceed its short term liabilities ($81.4M).
Long Term Liabilities: CDNA's short term assets ($334.1M) exceed its long term liabilities ($122.3M).
Debt to Equity History and Analysis
Debt Level: CDNA is debt free.
Reducing Debt: CDNA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CDNA has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CDNA is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 22.2% per year.